American Society of Clinical Oncology: Olanzapine Reduces Nausea and Improves Quality of Life for Patients With Cancer During Chemotherapy
September 24, 2024
September 24, 2024
ALEXANDRIA, Virginia, Sept. 24 (TNSres) -- The Association for Clinical Oncology, a members of the American Society of Clinical Oncology, issued the following news release:
* * *
New Research Will Be Presented at 2024 ASCO Quality Care Symposium
* * *
ASCO Perspective Quote
"Chemotherapy-induced nausea is a highly prevalent and distressing side effect of chemotherapy, which significantly impairs patients' quality of life. . . .
* * *
New Research Will Be Presented at 2024 ASCO Quality Care Symposium
* * *
ASCO Perspective Quote
"Chemotherapy-induced nausea is a highly prevalent and distressing side effect of chemotherapy, which significantly impairs patients' quality of life. . . .